glp and glp 1 Comparing Ozempic, Wegovy Other GLP-1 Drugs GLP-1 Receptor Agonists – Peripheral
Description
Discover the transformative impact of GLP-1 agonists, originally a diabetes treatment, on thousands of peoples weight-loss journey.
Thats why the FDA gives it a boxed warning
Objective To assess whether use of glucagon-like peptide-1 (GLP-1) receptor agonists before upper gastrointestinal endoscopy is associated with increased risk of pulmonary aspiration or discontinuation of the procedure compared with sodium-glucose cotransporter-2 (SGLT-2) inhibitors
Tirzepatide 15 mg led to higher discontinuation rate of study medication due to adverse events regardless of comparator, while all tirzepatide doses were safe in terms of serious adverse events and mortality
However, the use of traditional anti-diabetic drugs, in most cases, does not significantly reduce macrovascular morbidity and mortality
New research suggests GLP-1s may reduce the risks of blood clots and early death in people with both obesity and autoimmune disease
